Epigral Ltd
NSE:EPIGRAL

Watchlist Manager
Epigral Ltd Logo
Epigral Ltd
NSE:EPIGRAL
Watchlist
Price: 2 121.1 INR 0.16% Market Closed
Market Cap: 88.1B INR
Have any thoughts about
Epigral Ltd?
Write Note

Intrinsic Value

The intrinsic value of one EPIGRAL stock under the Base Case scenario is 1 809.82 INR. Compared to the current market price of 2 121.1 INR, Epigral Ltd is Overvalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EPIGRAL Intrinsic Value
1 809.82 INR
Overvaluation 15%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Epigral Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for EPIGRAL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about EPIGRAL?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Chemicals Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Epigral Ltd

Provide an overview of the primary business activities
of Epigral Ltd.

What unique competitive advantages
does Epigral Ltd hold over its rivals?

What risks and challenges
does Epigral Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Epigral Ltd.

Provide P/S
for Epigral Ltd.

Provide P/E
for Epigral Ltd.

Provide P/OCF
for Epigral Ltd.

Provide P/FCFE
for Epigral Ltd.

Provide P/B
for Epigral Ltd.

Provide EV/S
for Epigral Ltd.

Provide EV/GP
for Epigral Ltd.

Provide EV/EBITDA
for Epigral Ltd.

Provide EV/EBIT
for Epigral Ltd.

Provide EV/OCF
for Epigral Ltd.

Provide EV/FCFF
for Epigral Ltd.

Provide EV/IC
for Epigral Ltd.

Show me price targets
for Epigral Ltd made by professional analysts.

What are the Revenue projections
for Epigral Ltd?

How accurate were the past Revenue estimates
for Epigral Ltd?

What are the Net Income projections
for Epigral Ltd?

How accurate were the past Net Income estimates
for Epigral Ltd?

What are the EPS projections
for Epigral Ltd?

How accurate were the past EPS estimates
for Epigral Ltd?

What are the EBIT projections
for Epigral Ltd?

How accurate were the past EBIT estimates
for Epigral Ltd?

Compare the revenue forecasts
for Epigral Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Epigral Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Epigral Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Epigral Ltd compared to its peers.

Compare the P/E ratios
of Epigral Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Epigral Ltd with its peers.

Analyze the financial leverage
of Epigral Ltd compared to its main competitors.

Show all profitability ratios
for Epigral Ltd.

Provide ROE
for Epigral Ltd.

Provide ROA
for Epigral Ltd.

Provide ROIC
for Epigral Ltd.

Provide ROCE
for Epigral Ltd.

Provide Gross Margin
for Epigral Ltd.

Provide Operating Margin
for Epigral Ltd.

Provide Net Margin
for Epigral Ltd.

Provide FCF Margin
for Epigral Ltd.

Show all solvency ratios
for Epigral Ltd.

Provide D/E Ratio
for Epigral Ltd.

Provide D/A Ratio
for Epigral Ltd.

Provide Interest Coverage Ratio
for Epigral Ltd.

Provide Altman Z-Score Ratio
for Epigral Ltd.

Provide Quick Ratio
for Epigral Ltd.

Provide Current Ratio
for Epigral Ltd.

Provide Cash Ratio
for Epigral Ltd.

What is the historical Revenue growth
over the last 5 years for Epigral Ltd?

What is the historical Net Income growth
over the last 5 years for Epigral Ltd?

What is the current Free Cash Flow
of Epigral Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Epigral Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Epigral Ltd

Balance Sheet Decomposition
Epigral Ltd

Current Assets 5B
Cash & Short-Term Investments 471.4m
Receivables 1.8B
Other Current Assets 2.8B
Non-Current Assets 22.9B
Long-Term Investments 291.1m
PP&E 22.3B
Intangibles 219.6m
Other Non-Current Assets 138.2m
Current Liabilities 7.8B
Accounts Payable 1.7B
Other Current Liabilities 6.1B
Non-Current Liabilities 7.6B
Long-Term Debt 5.5B
Other Non-Current Liabilities 2.1B
Efficiency

Earnings Waterfall
Epigral Ltd

Revenue
21.3B INR
Cost of Revenue
-12.6B INR
Gross Profit
8.6B INR
Operating Expenses
-4.2B INR
Operating Income
4.4B INR
Other Expenses
-1.9B INR
Net Income
2.5B INR

Free Cash Flow Analysis
Epigral Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

EPIGRAL Profitability Score
Profitability Due Diligence

Epigral Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Exceptional Revenue Growth Forecast
Positive Operating Income
57/100
Profitability
Score

Epigral Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

EPIGRAL Solvency Score
Solvency Due Diligence

Epigral Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Low D/E
High Altman Z-Score
Long-Term Solvency
Short-Term Solvency
45/100
Solvency
Score

Epigral Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EPIGRAL Price Targets Summary
Epigral Ltd

Wall Street analysts forecast EPIGRAL stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EPIGRAL is 2 040 INR with a low forecast of 2 020 INR and a high forecast of 2 100 INR.

Lowest
Price Target
2 020 INR
5% Downside
Average
Price Target
2 040 INR
4% Downside
Highest
Price Target
2 100 INR
1% Downside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for EPIGRAL?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for EPIGRAL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Epigral Ltd Logo
Epigral Ltd

Country

India

Industry

Chemicals

Market Cap

88.1B INR

Dividend Yield

0.24%

Description

Meghmani Finechem Ltd. engages in the manufacture of chemicals involved in pigments and pesticides. The company is headquartered in Ahmedabad, Gujarat and currently employs 936 full-time employees. The company went IPO on 2021-08-18. The firm is engaged in manufacturing and selling chlor alkali and its derivatives. The company is also engaged in the trading of agrochemical products. The firm manufactures a range of products, such as chlorinated polyvinyl chloride (CPVC) resin, caustic soda, caustic potash, chlorine, hydrogen, chloromethanes, and hydrogen peroxide. The Company’s products are used in alumina, textile, crop protection, refineries, pharmaceutical, paper & pulp, soaps & detergent, and other industries. The Company’s subsidiaries include Meghmani Advanced Sciences Limited.

Contact

GUJARAT
Ahmedabad
Meghmani House, B/h Safal Profitaire,, Corporate Road, Prahladnagar
+917929709600
www.meghmanifinechem.com

IPO

2021-08-18

Employees

936

Officers

Chairman & MD
Mr. Maulik Jayantibhai Patel
CEO & Executive Director
Mr. Kaushal Ashisbhai Soparkar
Chief Financial Officer
Mr. Sanjay Jain
Senior Vice President of Operations
Vijay Vasudeva
Company Secretary & Compliance Officer
Mr. Gaurang G. Trivedi
Senior General Manager of Marketing
Naresh Kumar Agarwal
Show More
Senior General Manager of Corporate Human Relations
Mr. Vikram Bhatt
Senior VP of Power Plant
R. S. Rajan
Head of H2O2 Process
Amritlal Rathod
Process Head of Technology
Jitesh Vaghani
Show Less

See Also

Discover More
What is the Intrinsic Value of one EPIGRAL stock?

The intrinsic value of one EPIGRAL stock under the Base Case scenario is 1 809.82 INR.

Is EPIGRAL stock undervalued or overvalued?

Compared to the current market price of 2 121.1 INR, Epigral Ltd is Overvalued by 15%.

Back to Top